NextCure, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Heller Kevin N. | Chief Medical Officer | Option Exercise | 27,229 | $1.77 | $48,195 | 49,011 | Jul 14, 2020 |
| Liu Linda | SVP, Research | Option Exercise | 20,745 | $1.21 | $25,101 | 55,234 | Nov 27, 2019 |
| Sofinnova Venture Partners IX, L.P. | — | Purchase | 150,000 | $36.75 | $5,512,500 | 2,671,856 | Nov 15, 2019 |
| Sofinnova Management IX, L.L.C. | — | C | 464,599 | — | — | 743,358 | May 13, 2019 |
| Alexandria Venture Investments, LLC | — | C | 197,993 | — | — | 197,993 | May 13, 2019 |
| SHANNON TIMOTHY M | — | Purchase | 50,000 | $15.00 | $750,000 | 2,254,442 | May 13, 2019 |
| Khuong Chau Quang | — | C | 442,438 | — | — | 2,361,013 | May 13, 2019 |
| Xu Stella | — | Purchase | 125,000 | $15.00 | $1,875,000 | 1,103,570 | May 13, 2019 |
| CANAAN X L.P. | — | C | 743,110 | — | — | 1,188,976 | May 13, 2019 |
| OrbiMed Capital GP VI LLC | — | Purchase | 350,000 | $15.00 | $5,250,000 | 2,711,013 | May 13, 2019 |